Publications

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

Download PDF
Resource: Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

.

Related Articles

Shared roles of immune and stromal cells in the pathogenesis of human bronchiolitis obliterans syndrome

Link
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma

Link